TNFSF10 and autoimmune lymphoproliferative syndrome: Animal studies have in fact shown that genetic loss of both FasL and TRAIL resulted in a condition that resembles to human autoimmune lymphoproliferative syndrome (ALPS), which is characterized by splenomegaly and lymphadenopathy, due to an accumulation of CD4−CD8− “double negative” T cells [29].